Oncquest blood home pickup

  • patients
  • doctors
  • care givers

Hereditary Cancer Testing

View / Download

1.DNA Genetic Cancer Risk Test (98 gene panel)    

  • Determine risk for 25 types of hereditary cancers, looks for mutations in 98 genes related to solid tumors.
  • Screening test for individuals who have family history of cancer or who want to know if they are at an increased risk for cancer.
  • Cover NCCN Guidelines gene and ACMG variant reporting
  • Give a detailed report on the presence of mutations associated with increased cancer risk

Who can test?

  • Healthy individuals who want to know if they are at an increased risk for cancer.

Individuals with a family history of cancer:

  • A combination (usually 2 or more) of cancers on the same side of the family.
  • A family member with breast, colorectal, endometrial, and possibly other types of cancers before age 50.
  • A family member with a rare (i.e. triple-negative breast cancer, ovarian cancer) cancer at any age.
  • Individuals with cancer who want to understand if their cancer was hereditary and if they are at an increased risk for other cancers.
DNA Genetic Cancer Risk Test  - 25 Major Cancer List
Breast Ovaries Endometrium, Uterine
Myometrium Uterine Prostate Gland Stomach
Large Bowel and Rectum Lung and Pleura Small Intestine
Esophagus Urinary Tract and Bladder Exocrine Pancreas
Endocrine Pancreas Kidneys Cervix
Skin Bone Thyroid Gland
Liver Soft Tissue Miscellaneous Endocrine Gland
Blood Head and Neck Central Nervous System
Peripheral Nervous System    

Early Cancer Detection

2. CRC Protect Test

  • Most sensitive test for the screening of early stage colorectal cancer (CRC) and precancerous lesions when disease is most curable
  • Accurate, non-invasive test for early detection of Colorectal cancer (CRC)
  • Circulating Tumor cell (CTC) identification based assay
  • Suitable for individuals who never been diagnosed with colorectal cancer

3. Prostate Cancer Test

  • Precise routine blood test that clarifies whether a patient can avoid painful diagnostic biopsy following inconclusive/gray zone results from PSA testing
  • Helps in Reducing Physician uncertainty and patient anxiety
  • Circulating Tumor cell (CTC) identification based test done on CMx platform
  • Suitable for men who never diagnosed with prostate cancer

Cancer Recurrence Monitoring

4. PanCA Monitor Test

  • Monitoring test for treatment effectiveness & early recurrence of solid tumors
  • Non-invasive, radiation free, routine recurrence monitoring for 17 different types of cancers.
  • Circulating tumor cell (CTC) identification-based test done on clinically proven CMx platform
PanCA Monitor Test – 17 cancer list
Colorectal Pancreatic
Breast Liver
Lung Hepatobiliary
Prostate Bladder
Ovarian Skin
Endometrial Head and Neck
Thyroid Esophagus
Small Intestine Gastric
  Renal cell carcinoma

Somatic Cancer Testing

5. LBx Multiorgan Somatic Mutation panel

  • Analysis of multiple solid tumors for 73 genes
  • Most comprehensive and NCCN guidelines complete test to detect somatic alterations
  • Helps in targeted therapy selection and treatment monitoring
  • Circulating tumor cell (CTC) identification-based test

6. PDL1 CTC Test

  • Assess PDL-1 expression in Lung cancer patients
  • Determine eligibility for immunotherapy
  • Circulating tumor cell (CTC) identification-based test done on CMX platform

7. Lung Cancer LBx panel + PDL1

  • Only NCCN guideline complete test for immunotherapy and targeted selection for patients with lung cancer
  • Non-invasive and highly sensitive blood test when tissue is not available
  • Offers timely insight during cancer management process
  • PDL1 testing by using Dako antibody
  • Testing is done using advanced Next Generation Sequencing (NGS) and sensitive CTC capture on CMx platform

8. Lung Cancer LBx (NGS only)

  • For target selection for patients with lung cancer
  • NCCN guideline complete test for cancer management
  • Done by using advanced Next Generation Sequencing (NGS)